IEX · News · 20261028N
Guidance and Outlook
IDEX CORP /DE/ · 2026-10-28 · Importance 62 · Surprise 68 · In source text
IDEX raised its full-year 2026 organic sales growth outlook to 6.5%–6.8%, from its prior range of 5%–6%. It also raised adjusted diluted EPS guidance to $8.91–$8.96, up from $8.70–$8.85. The updated outlook followed third-quarter results that exceeded management’s expectations.
Key facts
- IDEX's FY2026 adjusted diluted EPS guidance was $8.91-$8.96, versus prior guidance of $8.70-$8.85 and consensus of $8.83. source
- IDEX's FY2026 adjusted diluted EPS guidance was $8.91-$8.96, versus consensus of $8.83 and prior guidance of $8.70-$8.85. source
- IDEX's FY2026 organic sales growth guidance was raised to 6.5%-6.8% from 5%-6%. source
- IDEX provided FY2026 EPS guidance of $8.91-$8.96, above analyst consensus of $8.83. source
- IDEX provided FY2026 adjusted EPS guidance of $8.91-$8.96 per share. source
- IDEX raised its full-year 2026 adjusted EPS guidance to $8.91-$8.96. source
- IDEX's FY2026 adjusted diluted EPS outlook was raised to $8.91-$8.96. source
- IDEX projected FY2026 organic sales growth of 6.5% to 6.8%. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | — | IDEX's FY2026 organic sales growth guidance was raised to 6.5%-6.8% from 5%-6%. |